[{"NetIncomeLossConverted_1_Q2_USD":-47010000.0,"NetIncomeLossConverted_2_Q2_USD":-76797000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":48422921.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":48326764.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-54632000.0,"CommonStockSharesOutstanding_0_Q2_shares":49103066.0,"StockholdersEquity_0_Q2_USD":496583000.0,"Assets_0_Q2_USD":520428000.0,"CommonStockSharesConverted_0_Q2_shares":49103066.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":48422921.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":48326764.0,"Ticker":"SWTX","CIK":"1773427","name":"SPRINGWORKS THERAPEUTICS, INC.","OfficialName":"SpringWorks Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2504354261.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]